Physician profile
Robert D Andersen
NPI 1588617427
$5,867.24
in general payments reported to CMS, 2019-2025
39 companies · $2,091 in 2025
The $2,091 reported for 2025 was more than what 81% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $381 · 2020: $105 · 2021: $176 · 2022: $276 · 2023: $1,474 · 2024: $1,363 · 2025: $2,091.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,750 · Education: $178.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,750.00 |
| Education | $177.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $957.18 | 2019-2025 | Erleada, Rybrevant, Carvykti |
| Pfizer INC. | $583.45 | 2019-2025 | |
| Astellas Pharma US INC | $540.91 | 2019-2025 | Xtandi, Myrbetriq |
| Sumitomo Pharma America, INC. | $468.01 | 2023-2025 | Gemtesa, Orgovyx |
| Endo USA, INC. | $387.19 | 2024-2025 | Xiaflex, Aveed |
| Abbvie INC. | $270.56 | 2020-2025 | Botox, Lupron Depot |
| C. R. Bard, INC. & Subsidiaries | $269.07 | 2024-2025 | Bard Urinary Drainage Bag |
| 180 Medical, INC. | $262.21 | 2023-2025 | |
| Endo Pharmaceuticals INC. | $241.69 | 2023-2024 | Xiaflex, Aveed |
| Urogen Pharma, INC. | $208.18 | 2023-2025 | Jelmyto |
| Procept Biorobotics Corporation | $155.47 | 2022-2025 | Aquabeam Robotic System |
| Tolmar, INC. | $144.61 | 2023-2025 | Jatenzo, Eligard |
| Boston Scientific Corporation | $143.94 | 2019-2025 | Axonics |
| Teleflex LLC | $126.36 | 2023-2025 | Urolift, Barrigel |
| Dendreon Pharmaceuticals LLC | $125.23 | 2024-2025 | Provenge |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Immunitybio, INC. | $108.82 | 2024-2025 | |
| Progenics Pharmaceuticals, INC. | $91.02 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $84.31 | 2020-2025 | Keytruda, Welireg, Zerbaxa |
| Ethicon US, LLC | $75.34 | 2023-2024 | Monocryl, Stratafix, Dermabond Prineo |
| Blue Earth Diagnostics | $70.52 | 2019-2023 | |
| Novartis Pharmaceuticals Corporation | $57.51 | 2020-2025 | |
| Karl Storz Endoscopy-America | $56.12 | 2023 | Hopkins |
| Calyxo, INC. | $49.49 | 2024-2025 | Cvac Aspiration System |
| Olympus America INC. | $41.70 | 2023-2025 | Evis Exera III Video System Center, Soltive |
| Bard Access Systems, INC. | $41.51 | 2019 | |
| Medtronic, INC. | $36.92 | 2023 | Ligasure |
| Axonics, INC. | $35.68 | 2023-2024 | Axonics, Bulkamid |
| Myriad Genetic Laboratories, INC. | $32.14 | 2023-2025 | Prolaris |
| Bioprotect Medical, INC. | $31.74 | 2025 | Bioprotect Balloon Implant System |
| Biotissue Holdings INC. | $30.44 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $25.97 | 2023 | Seglentis |
| Ferring Pharmaceuticals INC. | $17.97 | 2025 | Adstiladrin |
| Sun Pharmaceutical Industries INC. | $17.42 | 2023 | Yonsa |
| Foundation Medicine, INC. | $16.05 | 2023 | Foundationone Cdx |
| Bayer Healthcare Pharmaceuticals INC. | $15.86 | 2024 | |
| Photocure INC | $14.01 | 2024 | Cysview |
| Dentsply Ih INC. | $12.75 | 2019 | |
| Coloplast Corp | $11.35 | 2019 | |
| Janssen Pharmaceuticals, INC | $8.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Andersen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.